|
KYTX Kyverna Therapeutics Inc 1994702 |
| Balance Sheet |
|
Current Assets
|
325,374,000 |
|
Assets
|
339,196,000 |
|
Current Liabilities
|
30,985,000 |
|
Liabilities
|
36,486,000 |
|
Equity
|
302,710,000 |
|
Shares Out
|
43,147,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-77,189,000 |
|
Investing Cash Flow
|
-190,124,000 |
| Market Analysis |
Market Cap
|
285,632,075 |
|
Price
|
2.28 |
|
BVPS
|
7.02 |
|
PB
|
0.34 |
|
PS
|
43520.92 |
|
FCF
|
-267,313,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KYTX documents filed with the SEC.
KYTX Filings
Clear
